Medicine for treating benign prostate hyperplasia

A technology for prostatic hyperplasia and medicine, applied in the field of western medicine

Inactive Publication Date: 2003-08-20
檀德宏
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The present invention solves the problem that the existing α-receptor blocking drugs are not enough to improve stimulation, dysuria and frequent urination, and provides a drug that has a good effect of improving poor urination, stimulation, dysuria and frequent urination

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Terazosin 2g, diclofenac 25g, and excipients are appropriate, and made into 2000 tablets, and the patient takes 2-4 tablets every day.

Embodiment 2

[0014] Doxazosin 2g, ibuprofen 200g, and appropriate amount of excipients are prepared into 2000 tablets, and the patient takes 2-4 tablets every day.

Embodiment 3

[0016] Prazosin 1g, launoxicam 2g, and appropriate amount of excipients were used to make 1000 transdermal plasters, which were replaced once a day by the patient.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The medicine for treating benign prostate hyperplasia is prepared with alpha receptor blocker and non-steroid antiphlogistic in the ratio of 1 to 0.01-10000 and through mixing. The medicine has excellent improving effect on dysuresis, irritation, painful micturition and frequency micturition.

Description

Technical field: [0001] The invention belongs to western medicine and is mainly used for treating benign prostatic hyperplasia. Background technique: [0002] Benign prostatic hyperplasia is a male age-related disease. Due to the influence of endocrine and other factors, as men grow older, the prostate tissue hyperplasia and hypertrophy, among which the smooth muscle tissue increases, exerts an oppressive effect on the urethra. Smooth muscle tissue contains a large number of α-receptors, and α-receptors combine with adrenergic neurotransmitters to contract smooth muscles and aggravate compression symptoms. Patients with prostatic hypertrophy will show symptoms such as poor urination, urinary retention, frequent urination, dysuria, nocturia, restless night sleep, and mental irritability. At present, the main treatment methods for benign prostatic hyperplasia are surgical treatment and drug treatment. The main drug methods are: 1. Hormone therapy: taking estrogen to fight a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/501A61P13/08
Inventor 檀德宏韩俊雁
Owner 檀德宏
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap